Decoy Therapeutics Inc. (DCOY) vs Jupiter Neurosciences, Inc. (JUNS)

A side-by-side comparison of Decoy Therapeutics Inc. and Jupiter Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DCOY

Decoy Therapeutics Inc.

$851149

$1.60HealthcareDelayed quote: Oct 6, 2026, 1:58 PM EDT

JUNS

Jupiter Neurosciences, Inc.

$1M

$2.95HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT

Total return — DCOY vs JUNS

growth of $100 · dividends reinvested · last 2y

DCOY -99.4% (-92.0%/yr)JUNS -99.4% (-92.3%/yr)DCOY compounded faster over this window

DCOY JUNS

DCOY vs JUNS: by the numbers

•JUNS is the larger company ($1M vs $851149 market cap).
•Both run net losses; DCOY's is the smaller (0.00% vs -14220.12% net margin).

Metrics side by side

Valuation

Metric	DCOY	JUNS
P/S ratio	N/A	22.10
P/B ratio	0.20	N/A

Profitability

Metric	DCOY	JUNS
Gross margin	0.00%	88.34%
Operating margin	0.00%	-40873.19%
Net margin	0.00%	-14220.12%
ROE	-334.41%	N/A
ROIC	-343.55%	-709.40%

Growth (annualized)

Metric	DCOY	JUNS
Revenue CAGR (5Y)	N/A	-47.77%
Total return CAGR (5Y)	-86.39%	N/A

Go deeper

Full DCOY analysis Full JUNS analysis Interactive comparison tool

Dig into the metrics

Decoy Therapeutics ROE Jupiter Neurosciences ROE Decoy Therapeutics operating margin Jupiter Neurosciences operating margin Decoy Therapeutics revenue growth Jupiter Neurosciences revenue growth Decoy Therapeutics free cash flow Jupiter Neurosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.